These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19779376)

  • 21. Severe cytomegalovirus enterocolitis in an immunocompetent infant.
    Rongkavilit C; Bedard MP; Ang JY; Asmar BI; Tolia V
    Pediatr Infect Dis J; 2004 Jun; 23(6):579-81. PubMed ID: 15194846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients.
    Casillo R; Grimaldi M; Ragone E; Maiello C; Marra C; De Santo L; Amarelli C; Romano G; Della Corte A; Portella G; Tripodi MF; Fortunato R; Cotrufo M; Utili R
    Transplant Proc; 2004 Apr; 36(3):651-3. PubMed ID: 15110622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus enterocolitis in an immunocompetent infant host: another cause of treatable intractable diarrhea in infancy.
    Quiros-Tejeira RE; Ament ME; Rivera-Penera T; Cortina G; Vargas JH
    J Pediatr Gastroenterol Nutr; 1999 Jul; 29(1):86-90. PubMed ID: 10400111
    [No Abstract]   [Full Text] [Related]  

  • 25. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T; Lai WK; Mutimer D
    Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment with oral valganciclovir of primary CMV enterocolitis in a congenitally infected infant.
    Irizarry K; Honigbaum S; Demmler-Harrison G; Rippel S; Wilsey M
    Fetal Pediatr Pathol; 2011; 30(6):437-41. PubMed ID: 21905765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is a 6-week course of ganciclovir therapy effective for chorioretinitis in infants with congenital cytomegalovirus infection?
    Shoji K; Ito N; Ito Y; Inoue N; Adachi S; Fujimaru T; Nakamura T; Nishina S; Azuma N; Saitoh A
    J Pediatr; 2010 Aug; 157(2):331-3. PubMed ID: 20400108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children.
    Nigro G; Krzysztofiak A; Bartmann U; Clerico A; Properzi E; Valia S; Castello M
    Arch Virol; 1997; 142(3):573-80. PubMed ID: 9349303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.
    Paya CV; Wilson JA; Espy MJ; Sia IG; DeBernardi MJ; Smith TF; Patel R; Jenkins G; Harmsen WS; Vanness DJ; Wiesner RH
    J Infect Dis; 2002 Apr; 185(7):854-60. PubMed ID: 11920308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytomegalovirus infection after heart transplantation. Retrospective analysis of an antiviral CMV prevention].
    Antretter H; Höfer D; Klaus A; Larcher C; Margreiter J; Margreiter R
    Dtsch Med Wochenschr; 2000 Apr; 125(15):445-51. PubMed ID: 10800441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral ganciclovir.
    Schouten JT
    STEP Perspect; 1995; 7(3):1, 11. PubMed ID: 11362979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation.
    Narimatsu H; Kami M; Kato D; Matsumura T; Murashige N; Kusumi E; Yuji K; Hori A; Shibata T; Masuoka K; Wake A; Miyakoshi S; Morinaga S; Taniguchi S
    Transpl Infect Dis; 2007 Mar; 9(1):11-5. PubMed ID: 17313465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients.
    Chee SP; Bacsal K; Jap A; Se-Thoe SY; Cheng CL; Tan BH
    Am J Ophthalmol; 2008 May; 145(5):834-40. PubMed ID: 18255045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient.
    Puliyanda DP; Silverman NS; Lehman D; Vo A; Bunnapradist S; Radha RK; Toyoda M; Jordan SC
    Transpl Infect Dis; 2005 Jun; 7(2):71-4. PubMed ID: 16150094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID; Syriopoulou VP; Chelioti H; Daikos GL; Stamatiades D; Kostakis A; Boletis JN
    Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of cytomegalovirus (CMV) retinitis with intravitreous ganciclovir in HIV-infected children.
    Surachatkumtonekul T; Chokephaibulkit K; Vanprapar N; Pamonvaechavan P
    J Med Assoc Thai; 2008 Mar; 91(3):331-7. PubMed ID: 18575285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interstitial pulmonitis due to the cytomegalovirus in an immunocompetent adolescent: treatment with ganciclovir].
    Pellegrini G; Collo G; Barbi M; Binda A; Masarone M
    Pediatr Med Chir; 1996; 18(3):315-7. PubMed ID: 8966135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.
    Gilbert C; LeBlanc MH; Boivin G
    Herpes; 2001 Nov; 8(3):80-2. PubMed ID: 11867025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.